Trial
NCT03006562
PREvention of VENous ThromboEmbolism Following Radical Prostatectomy
Phase IVTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Prostate Cancer
Intervention
Subcutaneous Heparin
Why stopped
Early stopping point based on 2nd interim analysis (planned per protocol)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-05